Invention Grant
- Patent Title: Variants of the lantibiotic MU1140 and other lantibiotics with improved pharmacological properties and structural features
-
Application No.: US14381420Application Date: 2013-02-22
-
Publication No.: US09963488B2Publication Date: 2018-05-08
- Inventor: Jeffrey D. Hillman , James Leif Smith , Shawanda R. Wilson-Stanford
- Applicant: Oragenics, Inc. , The Texas A&M University System
- Applicant Address: US FL Alachua US TX College Station
- Assignee: Oragenics, Inc.,The Texas A&M University System
- Current Assignee: Oragenics, Inc.,The Texas A&M University System
- Current Assignee Address: US FL Alachua US TX College Station
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- International Application: PCT/US2013/027336 WO 20130222
- International Announcement: WO2013/130349 WO 20130906
- Main IPC: C07K14/195
- IPC: C07K14/195 ; A61K39/09 ; C07K14/315 ; A23G4/12 ; A23L2/52 ; A61K8/99 ; A61K35/744 ; A61Q11/00 ; C12N9/04 ; A01N25/34 ; A01N63/02 ; A61K38/16 ; A61K45/06 ; A61K8/64 ; A61K39/02 ; A61K38/12

Abstract:
The invention provides improvements of lantibiotics useful for reducing the numbers of microbes or the reproduction of microbes in or on subjects or objects. One embodiment of the invention provides variants of antibiotics wherein the amino acid at position (1) is changed to Ile or Gly, the amino acid at position (4) is changed to an Ala, the amino acid at position (4) is removed, the amino acid at position (5) is changed to an Ala, or wherein, as in the case of MU1140, the amino acid at position (13) is Arg, the Arg at position (13) is substituted with Asp, or combinations of two or more these changes or a pharmaceutically acceptable salt thereof.
Public/Granted literature
Information query